96 related articles for article (PubMed ID: 2922068)
1. [Extrapyramidal movement disorders following the use of flunarizine].
Petri H
Ned Tijdschr Geneeskd; 1989 Jan; 133(3):131. PubMed ID: 2922068
[No Abstract] [Full Text] [Related]
2. [Extrapyramidal movement disorders following administration of flunarizine].
Jongerius AM; van Gool AR
Ned Tijdschr Geneeskd; 1989 Apr; 133(14):746-7. PubMed ID: 2716906
[No Abstract] [Full Text] [Related]
3. [Extrapyramidal syndrome during treatment with flunarizine].
Bakchine S; Lacomblez L; Soubrié C
Rev Neurol (Paris); 1988; 144(12):833-4. PubMed ID: 3070697
[TBL] [Abstract][Full Text] [Related]
4. [Outcome of an extrapyramidal syndrome during prophylactic treatment of migraine with flunarizine].
Rostin M; Montastruc JL; Guiraud-Chaumeil B; Rascol A
Therapie; 1988 May; 43(3):242. PubMed ID: 3420574
[No Abstract] [Full Text] [Related]
5. [Extrapyramidal syndromes caused by flunarizine. Apropos of 6 cases].
Senard JM; Colomes M; Rostin M; Clanet M; Montastruc JL
Therapie; 1990; 45(2):157-9. PubMed ID: 2353329
[TBL] [Abstract][Full Text] [Related]
6. Extrapyramidal syndrome and depression induced by flunarizine.
Lugaresi A; Montagna P; Gallassi R; Lugaresi E
Eur Neurol; 1988; 28(4):208-11. PubMed ID: 3416889
[TBL] [Abstract][Full Text] [Related]
7. Movement disorders and depression due to flunarizine and cinnarizine.
Micheli FE; Pardal MM; Giannaula R; Gatto M; Parera I; Paradiso G; Torres M; Pikielny R; Pardal J
Mov Disord; 1989; 4(2):139-46. PubMed ID: 2733706
[TBL] [Abstract][Full Text] [Related]
8. Extrapyramidal and depressive side reactions with flunarizine and cinarizine.
Mangone CA; Herskovits E
J Neurol Neurosurg Psychiatry; 1989 Feb; 52(2):288-9. PubMed ID: 2703850
[No Abstract] [Full Text] [Related]
9. [Extrapyramidal movement disorders following the use of flunarizine].
Assmann VC; Perquin WV; Touw DJ
Ned Tijdschr Geneeskd; 1988 Oct; 132(42):1940-3. PubMed ID: 3185792
[No Abstract] [Full Text] [Related]
10. Useless drugs are not placebos: lessons from flunarizine and cinnarizine.
Laporte JR; Capella D
Lancet; 1986 Oct; 2(8511):853-4. PubMed ID: 2876292
[No Abstract] [Full Text] [Related]
11. Extrapyramidal symptoms associated with calcium-channel blockers.
Daniel JR; Mauro VF
Ann Pharmacother; 1995 Jan; 29(1):73-5. PubMed ID: 7711350
[TBL] [Abstract][Full Text] [Related]
12. Extrapyramidal side-effects of flunarizine.
De Michele G; Filla A; Coppola N; Mansi D; Brescia Morra ; Buscaino GA
Acta Neurol (Napoli); 1987 Jun; 9(3):230-3. PubMed ID: 3630796
[No Abstract] [Full Text] [Related]
13. Extrapyramidal symptoms and flunarizine.
Amery WK
Funct Neurol; 1987; 2(3):363-4. PubMed ID: 3692277
[No Abstract] [Full Text] [Related]
14. The prevalence of metoclopramide-induced tardive dyskinesia and acute extrapyramidal movement disorders.
Ganzini L; Casey DE; Hoffman WF; McCall AL
Arch Intern Med; 1993 Jun; 153(12):1469-75. PubMed ID: 8512437
[TBL] [Abstract][Full Text] [Related]
15. [Late irreversible extrapyramidal syndrome following neuroleptic use].
Boucebci M
Acta Psychiatr Belg; 1972 Mar; 72(2):233-40. PubMed ID: 5056017
[No Abstract] [Full Text] [Related]
16. Parkinson-like side effects during prolonged treatment with flunarizine.
Di Rosa AE; Morgante L; Meduri M; Musolino R; Leggiadro N; Coraci M; Crisafulli A; Di Perri R
Funct Neurol; 1987; 2(1):47-50. PubMed ID: 3315874
[TBL] [Abstract][Full Text] [Related]
17. Extrapyramidal symptoms and flunarizine.
Di Rosa A
Funct Neurol; 1988; 3(2):237-8. PubMed ID: 3402820
[No Abstract] [Full Text] [Related]
18. Useless drugs are not placebos.
Laporte JR; Capellà D
Lancet; 1987 Jun; 1(8545):1324. PubMed ID: 2884448
[No Abstract] [Full Text] [Related]
19. Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness.
Honer WG; Kopala LC; Rabinowitz J
J Psychopharmacol; 2005 May; 19(3):277-85. PubMed ID: 15888513
[TBL] [Abstract][Full Text] [Related]
20. Extrapyramidal effects of benzamides.
Chouza C; Caamano JL; Romero S; Lorenzo J; Feres S
Adv Biochem Psychopharmacol; 1985; 40():43-6. PubMed ID: 4025040
[No Abstract] [Full Text] [Related]
[Next] [New Search]
